Teva Pharmaceutical Industries Ltd.

Pharmaceuticals
Israel
Earnings Per Share Growth (%)-48.88%
Cost of Goods Sold (US$ Millions)$8,296
Current Liabilities (US$ Millions)$13,005
Total Assets (US$ Millions)$18,398
Long Term Debt$8,383
Return on Equity6.81%
Revenue (US$ Millions)$19,652
Total Company Assets$54,258
Revenue Growth (%)-3.06%
Net Income (US$ Millions)$1,588
Earnings Per Share (US$)($48.88)
Total Equity (US$ Millions)$29,769
Profit Margin (%)8.08%
Debt To Equity Ratio (%)0.28%
Inventory Turnover$3,966